Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
NCT06905262 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2025-04-01
Summary
Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: From Benchside to Bedside (HepAnt) - Study of the Role of the Metagenome in Head and Neck Tumors Using Omics Techniques (HeNomics).
Conditions
Sponsors & Collaborators
-
National Cancer Institute, Naples
lead OTHER
Principal Investigators
-
Luigi Buonaguro · IRCCS I.N.T. "G. Pascale"
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-02
- Primary Completion
- 2025-09-30
- Completion
- 2025-09-30
Countries
- Italy
Study Locations
More Related Trials
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer
NCT06800469 ·Status: RECRUITING ·Phase: NA
-
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCT05600933 ·Status: ENROLLING_BY_INVITATION
-
"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.
NCT05818865 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Hair Samples From Patients With Cancer
NCT00899691 ·Status: COMPLETED
-
Multi-analyte Blood Test Clinical Trial
NCT05199259 ·Status: RECRUITING
-
Analysis of Molecular Biomarkers in Periocular Adnexal Tumours
NCT06080009 ·Status: RECRUITING ·Phase: NA
-
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
NCT06744296 ·Status: RECRUITING
-
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
NCT07149207 ·Status: RECRUITING ·Phase: PHASE2
-
Omics of Cancer: OncoGenomics
NCT05431439 ·Status: WITHDRAWN
-
The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
NCT06717295 ·Status: RECRUITING
-
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
NCT03628651 ·Status: COMPLETED
-
The ONCOCAMP Study
NCT06270602 ·Status: RECRUITING
-
Contribution of Residual Tumour DNA Testing on the Surgical Bed
NCT05934929 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
NCT02682667 ·Status: RECRUITING
-
Clinical Evaluation of the Scopio Cell Morphology Technology
NCT06574308 ·Status: NOT_YET_RECRUITING
-
Versatile Ampification Single-Molecule Detection in Liquid Biopsy
NCT05940311 ·Status: RECRUITING
-
Proteogenomic Signatures Analysis In Ovarian Cancer
NCT05953883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Microbiome in Head and Neck Squamous Cell Carcinoma
NCT05837221 ·Status: RECRUITING
-
Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
NCT00369109 ·Status: COMPLETED
-
Circulating Tumor Cells in Solid Tumors
NCT03161821 ·Status: COMPLETED
-
NMR Metabolomics Study of Follicular Fluid of Oncological Patients
NCT04101981 ·Status: COMPLETED
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
NCT01915225 ·Status: RECRUITING
-
A Multicenter Cancer Biospecimen Collection Study
NCT04510129 ·Status: RECRUITING